EMA Authorised: Emtricitabine/Tenofovir disoproxil Krka d.d. (emtricitabine;tenofovir disoproxil succinate) — KRKA, d.d., Novo mesto

View source ↗

Summary

The European Medicines Agency authorised a fixed-dose combination antiretroviral therapy of emtricitabine and tenofovir disoproxil succinate (emtricitabine/teno…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• HIV Infection

Drugs mentioned

• emtricitabine/tenofovir disoproxil KRKA d.d. (emtricitabine; tenofovir disoproxil succinate)

Snippet

Status: Authorised. Therapeutic area: HIV Infections. MAH: KRKA, d.d., Novo mesto. Decision date: 31/01/2025